Innovative Synoptic Reporting With Seven-Point Sampling Protocol to Improve Detection Rate of Microvascular Invasion in Hepatocellular Carcinoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Nov 22

PMID 34804920

Citations 4

Authors

Bing Liao

Lijuan Liu

Lihong Wei

Yuefeng Wang

Lili Chen

Qinghua Cao

Qian Zhou

Han Xiao

Shuling Chen

Sui Peng

Shaoqiang Li

Ming Kuang

Affiliations

Soon will be listed here.

Abstract

Pathological MVI diagnosis could help to determine the prognosis and need for adjuvant therapy in hepatocellular carcinoma (HCC). However, narrative reporting (NR) would miss relevant clinical information and non-standardized sampling would underestimate MVI detection. Our objective was to explore the impact of innovative synoptic reporting (SR) and seven-point sampling (SPRING) protocol on microvascular invasion (MVI) rate and patient outcomes. In retrospective cohort, we extracted MVI status from NR in three centers and re-reviewed specimen sections by SR recommended by the College of American Pathologists (CAP) in our center. In prospective cohort, our center implemented the SPRING protocol, and external centers remained traditional pathological examination. MVI rate was compared between our center and external centers in both cohorts. Recurrence-free survival (RFS) before and after implementation was calculated by Kaplan-Meier method and compared by the log-rank test. In retrospective study, we found there was no significant difference in MVI rate between our center and external centers [10.3% (115/1112) 12.4% (35/282), P=0.316]. In our center, SR recommended by CAP improved the MVI detection rate from 10.3 to 38.6% (P<0.001). In prospective study, the MVI rate in our center under SPRING was significantly higher than external centers (53.2 17%, P<0.001). RFS of MVI (-) patients improved after SPRING in our center (P=0.010), but it remained unchanged in MVI (+) patients (P=0.200). We conclude that the SR recommended by CAP could help to improve MVI detection rate. Our SPRING protocol could help to further improve the MVI rate and optimize prognostic stratification for HCC patients.

Citing Articles

Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.

Akula V, Chen L, Acikgoz Y, Klein K, Yavuz B, Cevik L NPJ Precis Oncol. 2025; 9(1):60.

PMID: 40050446 PMC: 11885445. DOI: 10.1038/s41698-025-00846-4.

A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study.

Wang H, Chen J, Yin S, Sheng X, Wang H, Lau W J Hepatocell Carcinoma. 2024; 11:191-206.

PMID: 38283692 PMC: 10822140. DOI: 10.2147/JHC.S447731.

Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma.

Han Z, Dai H, Chen X, Gao L, Chen X, Yan C Front Physiol. 2023; 14:1138239.

PMID: 37601639 PMC: 10435992. DOI: 10.3389/fphys.2023.1138239.

Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.

Luo L, Shan R, Cui L, Wu Z, Qian J, Tu S United European Gastroenterol J. 2023; 11(2):228-241.

PMID: 36905230 PMC: 10039794. DOI: 10.1002/ueg2.12365.

Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.

Chen Y, Qin Y, Wu Y, Wei H, Wei Y, Zhang Z Front Immunol. 2022; 13:973153.

PMID: 36091074 PMC: 9453305. DOI: 10.3389/fimmu.2022.973153.

References

Srigley J, Lankshear S, Brierley J, McGowan T, Divaris D, Yurcan M . Closing the quality loop: facilitating improvement in oncology practice through timely access to clinical performance indicators. J Oncol Pract. 2013; 9(5):e255-61. DOI: 10.1200/JOP.2012.000818. View

Fonseca G, Herman P, Faraj S, Kruger J, Coelho F, Jeismann V . Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology. 2017; 72(3):377-390. DOI: 10.1111/his.13378. View

Meng R, Wei K, Xia L, Xu Y, Chen W, Zheng R . Cancer incidence and mortality in Guangdong province, 2012. Chin J Cancer Res. 2016; 28(3):311-20. PMC: 4949276. DOI: 10.21147/j.issn.1000-9604.2016.03.05. View

Bernal J, Cummins S, Gasparrini A . Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2016; 46(1):348-355. PMC: 5407170. DOI: 10.1093/ije/dyw098. View

Nakhleh R, Gephardt G, Zarbo R . Necessity of clinical information in surgical pathology. Arch Pathol Lab Med. 1999; 123(7):615-9. DOI: 10.5858/1999-123-0615-NOCIIS. View

Chen L, Chen S, Zhou Q, Cao Q, Dong Y, Feng S . Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol. Ann Surg Oncol. 2021; 28(11):6747-6757. DOI: 10.1245/s10434-021-09673-w. View

Liu C, Sun L, Xu J, Zhao Y . Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma. World J Surg Oncol. 2016; 14:100. PMC: 4818880. DOI: 10.1186/s12957-016-0855-z. View

Solomon D, Davey D, Kurman R, Moriarty A, OConnor D, Prey M . The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16):2114-9. DOI: 10.1001/jama.287.16.2114. View

Wang Y, Wang L, Xu D, Liu M, Wang H, Wang K . Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion. HPB (Oxford). 2018; 21(4):425-433. DOI: 10.1016/j.hpb.2018.08.001. View

10.

Wei W, Jian P, Li S, Guo Z, Zhang Y, Ling Y . Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Cancer Commun (Lond). 2018; 38(1):61. PMC: 6235393. DOI: 10.1186/s40880-018-0331-y. View

11.

Messenger D, McLeod R, Kirsch R . What impact has the introduction of a synoptic report for rectal cancer had on reporting outcomes for specialist gastrointestinal and nongastrointestinal pathologists?. Arch Pathol Lab Med. 2011; 135(11):1471-5. DOI: 10.5858/arpa.2010-0558-OA. View

12.

Raab S, Grzybicki D . Quality in cancer diagnosis. CA Cancer J Clin. 2010; 60(3):139-65. DOI: 10.3322/caac.20068. View

13.

Fan S, Poon R, Yeung C, Lam C, Lo C, Yuen W . Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg. 2011; 98(9):1292-300. DOI: 10.1002/bjs.7583. View

14.

Westgaard A, Clausen O, Gladhaug I . Survival estimates after pancreatoduodenectomy skewed by non-standardized histopathology reports. APMIS. 2011; 119(10):689-700. DOI: 10.1111/j.1600-0463.2011.02783.x. View

15.

Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot F, Regimbeau J . Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. J Hepatol. 2012; 56(5):1121-1128. DOI: 10.1016/j.jhep.2011.12.010. View

16.

Ruby S . Protocol for the examination of specimens from patients with hepatocellular carcinoma and cholangiocarcinoma, including intrahepatic bile ducts. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 2000; 124(1):41-5. DOI: 10.5858/2000-124-0041-PFTEOS. View

17.

Raab S, Andrew-Jaja C, Grzybicki D, Vrbin C, Chesin C, Fisch J . Dissemination of Lean methods to improve Pap testing quality and patient safety. J Low Genit Tract Dis. 2008; 12(2):103-10. DOI: 10.1097/LGT.0b013e31815ae9a1. View

18.

Renshaw A, Mena-Allauca M, Gould E, Sirintrapun S . Synoptic Reporting: Evidence-Based Review and Future Directions. JCO Clin Cancer Inform. 2019; 2:1-9. PMC: 6873952. DOI: 10.1200/CCI.17.00088. View

19.

Sluijter C, van Lonkhuijzen L, van Slooten H, Nagtegaal I, Overbeek L . The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review. Virchows Arch. 2016; 468(6):639-49. PMC: 4887530. DOI: 10.1007/s00428-016-1935-8. View

20.

Sun J, Wang K, Zhang C, Guo W, Shi J, Cong W . Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion. Ann Surg Oncol. 2015; 23(4):1344-51. DOI: 10.1245/s10434-015-5008-z. View